| Role |
Name |
Disclosure |
Details |
| Author | Robert A Gabbay, MD, PhD, Associate Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, Laurence M Demers Career Development Professor, Penn State College of Medicine; Director, Diabetes Program, Penn State Milton S Hershey Medical Center; Executive Director, Penn State Institute for Diabetes and Obesity | Pfizer, Novo Nordisk, Merck | Details | | Coauthor | Nazia Raja-Khan, MD, Assistant Professor of Medicine, Department of Endocrinology, Penn State University College of Medicine | Nothing to disclose | Details | | Coauthor | Elif Arioglu, MD, Assistant Professor of Medicine, Division of Endocrinology and Metabolism, University of Michigan | Nothing to disclose | Details | | Medical Editor | David M Klachko, MBBCh, Professor Emeritus, Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS, Affiliate Research Professor, School of Computational Sciences; Principal, Bioinformatics and Computational Biology Program, C/A Informatics, LLC | Nothing to disclose | Details | | CME Editor | Mark Cooper, MBBS, PhD, FRACP, Head, Diabetes & Metabolism Division, Baker Heart Research Institute, Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | George T Griffing, MD, Professor of Medicine, St Louis University School of Medicine | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Elif Arioglu, Coauthor |
The contributor discloses no conflict of interest. |
|